Dr Hazrat Bilal

Central Laboratory, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, P.R. China

Dr. Hazrat Bilal is an accomplished Microbiologist and Associate Researcher/Professor at the Central Laboratory, Jiangxi Cancer Hospital and Institute, Nanchang, China. His research expertise spans bacterial and fungal pathogens, with a dedicated focus on antimicrobial resistance and their implications in immunocompromised populations, particularly cancer patients.

Dr. Bilal’s academic journey is marked by excellence. He earned his Bachelor's degree from Hazara University and his Master’s from Khyber Medical University, both with highest honors, receiving gold medals for academic distinction. He went on to complete his Ph.D. in Ecology with a specialization in Microbiology at Anhui University, China, under a prestigious, fully-funded Chinese Government Scholarship. His doctoral research provided in-depth insights into the systematic analysis and molecular epidemiology of carbapenem- and colistin-resistant bacterial pathogens.

Following his Ph.D., Dr. Bilal completed postdoctoral training in Clinical Medicine at the Second Affiliated Hospital of Shantou University Medical College. There, he specialized in antimicrobial resistance mechanisms and molecular epidemiology of both fungal and bacterial clinical isolates, solidifying his role as a leading expert in translational infectious disease research.
Currently, Dr. Bilal’s research addresses the growing threat of multidrug-resistant pathogens among oncology patients. His work focuses on resistant bacterial and fungal isolates, as well as the oncogenic and immunomodulatory roles of fungi in various cancers. He also explores the potential of integrated diagnostic and surveillance tools to track and mitigate resistant infections in clinical settings.

Dr. Bilal is an active member of the American Society for Microbiology and serves as a reviewer for several high-impact international journals. His contributions to scientific literature and international conferences have advanced understanding in the fields of infectious diseases, cancer microbiology, and antimicrobial resistance.
With a proven track record in laboratory diagnostics, molecular techniques, and data analysis, Dr. Bilal continues to collaborate with global researchers to enhance infection control strategies and improve clinical outcomes for vulnerable patient populations.

Updated 19 June 2025